Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Nov;24(11):899-905.
doi: 10.1089/hum.2013.2511.

Dr. Sonia Skarlatos and the National Heart, Lung, and Blood institute translational research and resource programs

Cheryl L McDonald  1
Affiliations
Review

Dr. Sonia Skarlatos and the National Heart, Lung, and Blood institute translational research and resource programs

Cheryl L McDonald. Hum Gene Ther. 2013 Nov.

Abstract

Sonia I. Skarlatos, PhD (September 28, 1953-August 6, 2013), was the deputy director of the Division of Cardiovascular Sciences at the National Heart, Lung, and Blood Institute (NHLBI). This article reviews her work in establishing, leading, or facilitating extramural translational research programs supported by the NHLBI, specifically focusing on her work as a consistent advocate for the advancement of gene and cell therapies.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
The GTRP booth at the 2009 ASGCT meeting in San Diego, California: Manning the booth are, seated on the left, Sonia Skarlatos and, on the right, Meg Diggins. Standing on the left is Eric Daniels, and Sue Sepelak is standing on the right. ASGCT, American Society of Gene & Cell Therapy; GTRP, Gene Therapy Resource Program.
FIG. 2.
FIG. 2.
Sonia and her legacy of the National Heart, Lung, and Blood Institute (NHLBI) programs. This figure shows the currently active translational research and resource programs available to gene and cell therapy researchers that the late Dr. Sonia Skarlatos established, led, or facilitated during her time at the NHLBI.
See this image and copyright information in PMC

References

    1. Blaese R.M. Culver K.W. Miller A.D., et al. T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science. 1995;270:475–480. - PubMed
    1. Boeke A. Doumas P. Reeves L., et al. Vector production in an academic environment: a tool to assess production costs. Hum. Gene Ther. Methods. 2013;24:49–57. - PMC - PubMed
    1. Buxton D.B. Skarlatos S.I. Support for cardiovascular cell therapy research at the National Heart, Lung, and Blood Institute. Circ. Res. 2012;110:1549–1555. - PubMed
    1. Collins F.S. Research agenda: opportunities for research and NIH. Science. 2010;327:36–37. - PubMed
    1. Department of Health and Human Services. National Gene Vector Biorepository and Coordinating Center (P40) NIH Solicitation. 2007. http://grants.nih.gov/grants/guide/rfa-files/RFA-RR-07-002.html. [Sep;2013 ]. http://grants.nih.gov/grants/guide/rfa-files/RFA-RR-07-002.html

LinkOut - more resources